VIENNA—Obesity and insulin resistance were named as important targets for primary prevention of breast cancer by Pamela J. Goodwin, MD, MSc, FRCPC, Professor of Medicine and Director of the Marvelle Koffler Breast Centre at the University of Toronto/Mount Sinai Hospital, Canada. Oncology Times reporter Sarah Maxwell asked her about the findings and recommendations to cancer doctors emerging from her long term investigations of these factors.
You may also like...
‘Rescanning’ Optimizes Pencil Beam Proton Delivery to Moving Lung Tumor 12 May, 2015 Trifluridine with Tipiracil Lifts Survival in Refractory Gastric Cancer 11 Oct, 2018 World Malaria Day 2012: Dr Chi Eziefula, LSHTM: Old Drug New Hopes 24 Apr, 2012 Rio Conference on Sustainable Development: “Health Should Be Top Priority” 7 Oct, 2012
- Previous story Targeting Bone Microenvironment in Breast Cancer
- Next story Targeting Emerging Drugable Pathways in Breast Cancer—Clinical Potential Assessed
- COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
- Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
- First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014
- Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014
- Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014